Diabetes groups caution doctors in prescribing Avandia

11/28/2007 | Reuters

The European Association for the Study of Diabetes and the American Diabetes Association urged greater caution in prescribing thiazolidediones, such as GlaxoSmithKline's Avandia and Takeda Pharmaceutical Co. Ltd.'s Actos, in light of recent reports linking Avandia to increased heart attack risk. Both drugs already carry strong warnings about heart failure risks.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX